AKYA – akoya biosciences, inc. (US:NASDAQ)
Stock Stats
News
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - OPTN, SLRN, AKYA, SHYF
Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities
Akoya Biosciences, Inc. (NASDAQ: AKYA) had its "equal weight" rating re-affirmed by analysts at Stephens. They now have a $1.80 price target on the stock, down previously from $3.50.
Akoya Biosciences, Inc. (NASDAQ: AKYA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $3.50 price target on the stock.
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
Form 425 Akoya Biosciences, Inc. Filed by: Akoya Biosciences, Inc.
Form 8-K Akoya Biosciences, Inc. For: Apr 02
Form 425 Akoya Biosciences, Inc. Filed by: Quanterix Corp
Form 4 Akoya Biosciences, Inc. For: Apr 01 Filed by: Ek John Frederick
Form 4 Akoya Biosciences, Inc. For: Mar 23 Filed by: McKelligon Brian
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.